Trial Profile
Phase I and II Clinical Studies of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules for the Treatment of Patients With Advanced Non-Small Cell Lung Cancer.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary) ; Carboplatin; Paclitaxel
- Indications Carcinoma; Non-small cell lung cancer
- Focus Adverse reactions
- 21 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 26 May 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Aug 2008 Planned end date (Dec 2010) added as reported by ClinicalTrials.gov